Paul Cordasco looks at the challenges of getting sell-side research coverage.
In the summer of 2002, Don Stewart was facing a big problem. The CFO of medical-device manufacturer Rita Medical found himself without a single brokerage analyst regularly producing research on his small company. In Wall Street parlance, he had no sell-side coverage.
Shortly after Rita Medical went public in 2000, analysts at two of the investment firms that had underwritten the company's IPO - Robertson, Stephens & Company, and Citigroup's Salomon ...